Format breadth versus rock-bottom advertising — and a shared obligation: proving that complex tier tables and thin documentation respectively still add up to an honest total.
The two models
Orderly Meds competes on format breadth — injectables plus oral formats across multiple dose tiers — which makes it a natural comparison shop but also multiplies the price-table complexity where teaser structures hide. Its dose-tier pricing is queued for verification; oral-format claims inherit our standing evidence caveats.
Remedy Meds advertises among the lowest entry prices in the category with public documentation we found thin — terms, fees, and clinical model details that resist verification from the outside. It carries our documentation flag: not an accusation, a demand for the paperwork before any figure is repeated here.
Verified vs pending — read this before the marketing
Neither provider on this page has completed price verification, so this comparison stays structural — business models, pricing architecture, and the questions each must answer — with zero advertised numbers repeated as facts. The only verified figures on this site today sit in the ledger.
Two different opacity risks
Orderly’s risk is complexity — many formats and dose tiers give teaser structures room to hide, so its verification pass must price every tier at maintenance. Remedy’s risk is scarcity — too little public paperwork to check at all, hence its flag. Opposite failure modes, one defense: the written-answer checklist in our teaser file.
Go deeper
Full files: Orderly Meds · Remedy Meds. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.